Twice-daily bictegravir during rifampicin-based tuberculosis therapy: A pragmatic alternative
{{output}}
HIV-tuberculosis coinfection remains a major global health challenge and the concomitant use of antiretroviral therapy with rifampicin-based tuberculosis treatment is frequently complicated by clinically relevant drug-drug interactions. Rifampicin strongly ind... ...